IL6 and COVID-19: Severe COVID-19 patients also mostly exerted viral infection-induced hyperinflammatory state, mainly characterized by sustained increases in TNF-α, IL-6, and IL-1 levels, and disrupted monocyte and dendritic cell phenotypes, which could ultimately contribute to poor prognosis and mortality [151, 156].